长非编码RNAs (lncRNAs) 在癌症发展:从STAT3信号通路到免疫逃避的新见解
Lie Ma1, XuQing Liu2, R Roopashree3
1Department of Pulmonary and Critical Care Medicine, The Sixth Medical Center of PLA General Hospital, Beijing, 110000, China.
Clinical and experimental medicine
|February 11, 2025
概括
长非编码RNAs (lncRNAs) 调节信号传感器和转录3 (STAT3) 途径的激活器,影响结肠直肠癌 (CRC) 的进展,转移和免疫反应. 本综述探讨了lncRNA-STAT3在CRC致癌和瘤微环境中的相互作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌 (CRC) 的进展和转移是由复杂的信号网络驱动的.
- 信号转换器和转录3激活器 (STAT3) 在细胞功能中至关重要,其失调与CRC有关.
- 长非编码RNAs (lncRNAs) 是癌症的关键调节者,影响像STAT3.3这样的信号通路.
研究的目的:
- 综合审查 lncRNAs 在结直肠癌中对STAT3信号传递的调节作用.
- 阐明lncRNA/STAT3途径在CRC致癌过程中的相互影响,包括扩散,亡,转移,耐药性和血管生成.
- 研究lncRNA/STAT3轴对瘤微环境中的免疫细胞功能的影响.
主要方法:
- 对研究 lncRNAs,STAT3 和结直肠癌的文献综述.
- 在表观遗传,转录和转录后层面对STAT3上 lncRNAs 的调节机制的分析.
- 检查lncRNA/STAT3轴在CRC进展和免疫调节中的作用.
主要成果:
- lncRNAs广泛调节STAT3信号,影响癌症的关键特征,如扩散和转移.
- lncRNA/STAT3轴在CRC的发展,进展和对治疗的反应中起着重要作用.
- lncRNAs通过STAT3调节免疫细胞功能,影响瘤微环境.
结论:
- lncRNA-STAT3轴是结直肠癌病原和进展的关键决定因素.
- 针对 lncRNA-STAT3 途径为CRC提供了一个有前途的治疗策略.
- 了解lncRNA-STAT3相互作用对于开发用于结直肠癌的新型免疫疗法至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


